Greater variability in cognitive decline in Lewy body dementia compared to Alzheimer’s disease

Manuscript Number: 

19-0731R2

Author(s): 
Dag Aarsland, Lasse M. Giil

Disclosures

Dag Aarsland

  • Consulting Fees:
    Dr Aarsland has received research support and/or honoraria from Astra-Zeneca, H. Lundbeck, Novartis Pharmaceuticals and GE Health, and served as paid consultant for H. Lundbeck, Eisai, Heptares, Mentis Cura, and Biogen
    Lecture Fees:
    Dr Aarsland has received research support and/or honoraria from Astra-Zeneca, H. Lundbeck, Novartis Pharmaceuticals and GE Health, and served as paid consultant for H. Lundbeck, Eisai, Heptares, Mentis Cura, and Biogen
    Grants
    • Agency: 
      Sanofi
      Dates: 
      2019-2020

Lasse M. Giil

  • Nothing to Disclose